Risk Factors for HIV Acquisition in a Prospective Nairobi-Based Female Sex Worker Cohort

AIDS and Behavior

Volumn 19, Issue 12, 2015, Pages 2204-2213

  McKinnon, Lyle R ^a,b,c   Izulla, Preston ^a   Nagelkerke, Nico ^d,e   Munyao, Julius ^a   Wanjiru, Tabitha ^a   Shaw, Souradet Y ^e   Gichuki, Richard ^a   Kariuki, Cecilia ^a   Muriuki, Festus ^a   Musyoki, Helgar ^f   Gakii, Gloria ^a   Gelmon, Lawrence ^a,e   Kaul, Rupert ^a,b,g   Kimani, Joshua ^a,e  

^a UNIVERSITY OF NAIROBI   (Kenya)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

^d UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^e UNIVERSITY OF MANITOBA   (Canada)

^f Ministry of Public Health and Sanitation   (Kenya)

^g UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Co factors of transmission; Female sex workers; HIV acquisition; HIV AIDS; Prospective cohort; Risk profile

Indexed keywords

ADULT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; PROSPECTIVE STUDY; RISK FACTOR; SEX WORKER; YOUNG ADULT;

ADULT; FEMALE; HIV INFECTIONS; HUMANS; KENYA; PROSPECTIVE STUDIES; RISK FACTORS; SEX WORKERS; YOUNG ADULT;

EID: 84944511131     PISSN: 10907165     EISSN: 15733254     Source Type: Journal    
DOI: 10.1007/s10461-015-1118-7     Document Type: Article

References (44)

1. Camacho R, Teófilo E. Antiretroviral therapy in treatment-naïve patients with HIV infection. Curr Opin HIV AIDS [Internet]. 2011;6 Suppl 1:S3–11. Available from: http://pubget.com/paper/22156777?institution=.
2. Gulick RM. Antiretroviral treatment 2010: progress and controversies. J Acquir Immune Defic Syndr [Internet]. 2010;55 Suppl 1:S43–8. Available from: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=21045599&retmode=ref&cmd=prlinks.
3. Karim SSA, Karim QA. Antiretroviral prophylaxis: a defining moment in HIV control. Lancet [Internet]. 2011;378(9809):e23–5. Available from: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=21771566&retmode=ref&cmd=prlinks.
4. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N. Engl. J. Med. [Internet]. 2000;342(13):921–9. Available from: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=10738050&retmode=ref&cmd=prlinks.
5. Baeten JM, Kahle E, Lingappa JR, Coombs RW, Delany-Moretlwe S, Nakku-Joloba E, et al. Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med. 2011;3(77):77ra29.
6. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.
7. Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet. 2010;375(9731):2092–8.
8. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168–74.
9. McKinnon LR, Kaul R. Quality and quantity: mucosal CD4 + T cells and HIV susceptibility. Curr Opin HIV AIDS. 2012;7(2):195–202.
10. Powers KA, Poole C, Pettifor AE, Cohen MS. Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. Lancet Infect Dis. 2008;8(9):553–63.
11. Galvin SR, Cohen MS. The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol [Internet]. 2004;2(1):33–42. Available from: http://www.nature.com/doifinder/10.1038/nrmicro794.
12. Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS [Internet]. 2006;20(1):73–83. Available from: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=16327322&retmode=ref&cmd=prlinks.
13. Low N, Chersich MF, Schmidlin K, Egger M, Francis SC, H H M van de Wijgert J, et al. Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis. Mofenson L, editor. PLoS Med. [Internet]. 20118(2):e1000416. doi:10.1371/journal.pmed.1000416.t005.
14. Padian NS, Manian S. The concurrency debate: time to put it to rest. The Lancet [Internet]. Elsevier Ltd; 2011;378(9787):203–4. doi:10.1016/S0140-6736(11)60974-4.
15. Chen L, Jha P, Stirling B, Sgaier SK, Daid T, Kaul R, et al. Sexual risk factors for HIV infection in early and advanced HIV epidemics in Sub-Saharan Africa: systematic overview of 68 epidemiological studies. Siegfried N, editor. PLoS One [Internet]. 2007;2(10):e1001. doi:10.1371/journal.pone.0001001.t002.
16. Powers KA, Ghani AC, Miller WC, Hoffman IF, Pettifor AE, Kamanga G, et al. The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet. 2011;378(9787):256–68.
17. Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane database of systematic reviews (Online) [Internet]. 2002;(1):CD003255. Available from: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=11869658&retmode=ref&cmd=prlinks.
18. Ao TTH, Sam NE, Masenga EJ, Seage GR, Kapiga SH. Human immunodeficiency virus type 1 among bar and hotel workers in northern Tanzania: the role of alcohol, sexual behavior, and herpes simplex virus type 2. Sex Transm Dis [Internet]. 2006;33(3):163–9. Available from: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=16505740&retmode=ref&cmd=prlinks.
19. Weiser SD, Leiter K, Heisler M, McFarland W, Percy-de Korte F, DeMonner SM, et al. A population-based study on alcohol and high-risk sexual behaviors in Botswana. PLoS Med. [Internet]. 2006;3(10):e392. Available from: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=17032060&retmode=ref&cmd=prlinks.
20. Kimani J, McKinnon LR, Wachihi C, Kusimba J, Gakii G, Birir S, et al. Enumeration of sex workers in the central business district of Nairobi, Kenya. PLoS One. 2013;8(1):e54354.
21. Kim AA, Hallett T, Stover J, Gouws E, Musinguzi J, Mureithi PK, et al. Estimating HIV incidence among Adults in Kenya and Uganda: a systematic comparison of multiple methods. Boni M, editor. PLoS One [Internet]. 2011;6(3):e17535. doi:10.1371/journal.pone.0017535.t001.
22. Watson-Jones D, Weiss HA, Rusizoka M, Changalucha J, Baisley K, Mugeye K, et al. Effect of herpes simplex suppression on incidence of hiv among women in Tanzania. N Engl J Med [Internet]. 2008;358(15):1560–71. doi:10.1056/NEJMoa0800260.
23. Kaul R, Kimani J, Nagelkerke NJ, Fonck K, Ngugi EN, Keli F, et al. Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial. JAMA. 2004;291(21):2555–62.
24. Kimani J, Kaul R, Nagelkerke NJD, Luo M, MacDonald KS, Ngugi E, et al. Reduced rates of HIV acquisition during unprotected sex by Kenyan female sex workers predating population declines in HIV prevalence. AIDS. 2008;22(1):131–7.
25. Nagelkerke N, de Vlas SJ, Jha P, Luo M, Plummer FA, Kaul R. Heterogeneity in host HIV susceptibility as a potential contributor to recent HIV prevalence declines in Africa. AIDS. 2009;23(1):125–30.
26. Fowke KR, Nagelkerke NJ, Kimani J, Simonsen JN, Anzala AO, Bwayo JJ, et al. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet [Internet]. 1996;348(9038):1347–51. Available from: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=8918278&retmode=ref&cmd=prlinks.
27. Mackelprang RD, Baeten JM, Donnell D, Celum C, Farquhar C, de Bruyn G, et al. Quantifying ongoing HIV-1 exposure in HIV-1-serodiscordant couples to identify individuals with potential host resistance to HIV-1. J Infect Dis [Internet]. 2012;206(8):1299–308. doi:10.1093/infdis/jis480.
28. Laga M, Manoka A, Kivuvu M, Malele B, Tuliza M, Nzila N, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS [Internet]. 1993;7(1):95–102. Available from: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=8442924&retmode=ref&cmd=prlinks.
29. Plummer FA. Heterosexual transmission of human immunodeficiency virus type 1 (HIV): interactions of conventional sexually transmitted diseases, hormonal contraception and HIV-1. AIDS Res. Hum Retroviruses [Internet]. 1998;14 Suppl 1:S5–10. Available from: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=9581877&retmode=ref&cmd=prlinks.
30. Atashili J, Poole C, Ndumbe PM, Adimora AA, Smith JS. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS [Internet]. 2008;22(12):1493–501. Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00002030-200807310-00013.
31. Morrison CS, Nanda K. Hormonal contraception and HIV: an unanswered question. Lancet Infect Dis [Internet]. Elsevier Ltd; 2011;12(1):2–3. doi:10.1016/S1473-3099(11)70254-7.
32. Marx PA, Spira AI, Gettie A, Dailey PJ, Veazey RS, Lackner AA, et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med [Internet]. 1996;2(10):1084–9. Available from: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=8837605&retmode=ref&cmd=prlinks.
33. Morrison CS, Chen P-L, Kwok C, Baeten JM, Brown J, Crook AM, et al. Hormonal contraception and the risk of hiv acquisition: an individual participant data meta-analysis. PLoS Med. 2015;12(1):e1001778.
34. Ralph LJ, McCoy SI, Shiu K, Padian NS. Hormonal contraceptive use and women’s risk of HIV acquisition: a meta-analysis of observational studies. Lancet Infect Dis. 2015;15(2):181–9.
35. Heffron R, Rees H, Mugo N, Baeten JM. Use of hormonal contraceptives and risk of HIV-1 transmission. Lancet Infect Dis [Internet]. Elsevier Ltd; 2012;12(7):510–1. doi:10.1016/S1473-3099(12)70153-6.
36. Rees Helen, ECHO Consortium. DMPA and HIV: why we need a trial. Contraception. 2014;90(4):354–6.
37. Plummer FA, Simonsen JN, Cameron DW, Ndinya-Achola JO, Kreiss JK, Gakinya MN, et al. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis [Internet]. 1991;163(2):233–9. Available from: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=1988508&retmode=ref&cmd=prlinks.
38. Tanfer K, Aral SO. Sexual intercourse during menstruation and self-reported sexually transmitted disease history among women. Sex Transm Dis [Internet]. 1996;23(5):395–401. Available from: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=8885071&retmode=ref&cmd=prlinks.
39. de Vincenzi I. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV. N Engl J Med [Internet]. 1994;331(6):341–6. Available from: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=8028613&retmode=ref&cmd=prlinks.
40. Martin HL, Nyange PM, Richardson BA, Lavreys L, Mandaliya K, Jackson DJ, et al. Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. J Infect Dis [Internet]. 1998;178(4):1053–9. Available from: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=9806034&retmode=ref&cmd=prlinks.
41. Lurie S. Does intercourse during menses increase the risk for sexually transmitted disease? Arch Gynecol Obstet. 2010;282(6):627–30.
42. Hofmeyr GJ, Singata-Madliki M, Lawrie TA, Temmerman M. Hypothesis: amenorrhea-inducing contraception may reduce HIV acquisition risk. Contraception. 2014;90(6):615–6.
43. Kersh EN, Henning T, Vishwanathan SA, Morris M, Butler K, Adams DR, et al. SHIV susceptibility changes during the menstrual cycle of pigtail macaques. J Med Primatol. 2014;43(5):310–6.
44. Anderson S-J, Cherutich P, Kilonzo N, Cremin I, Fecht D, Kimanga D, et al. Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study. Lancet. 2014;384(9939):249–56.